Literature DB >> 11302793

Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.

H Yano1, A Kuga, R Okamoto, H Kitasato, T Kobayashi, M Inoue.   

Abstract

In 1996, Serratia marcescens KU3838 was isolated from the urine of a patient with a urinary tract infection at a hospital in northern Japan and was found to contain the plasmid pKU501. Previously, we determined that pKU501 carries bla(IMP) and the genes for TEM-1-type beta-lactamases as well as producing both types of beta-lactamases (H. Yano, A. Kuga, K. Irinoda, R. Okamoto, T. Kobayashi, and M. Inoue, J. Antibiot. 52:1135-1139, 1999). pKU502 is a recombinant plasmid that contains a 1.5-kb DNA fragment, including the metallo-beta-lactamase gene, and is obtained by PCR amplification of pKU501. The sequence of the metallo-beta-lactamase gene in pKU502 was determined and revealed that this metallo-beta-lactamase gene differed from the gene encoding IMP-1 by one point mutation, leading to one amino acid substitution: 640-A in the base sequence of the IMP-1 gene was replaced by G, and Ser-196 was replaced by Gly in the mature enzyme. This enzyme was designated IMP-6. The strains that produced IMP-6 were resistant to carbapenems. The MICs of panipenem and especially meropenem were higher than the MIC of imipenem for these strains. The k(cat)/K(m) value of IMP-6 was about sevenfold higher against meropenem than against imipenem, although the MIC of meropenem for KU1917, which produced IMP-1, was lower than that of imipenem, and the MIC of panipenem was equal to that of imipenem. These results support the hypothesis that IMP-6 has extended substrate profiles against carbapenems. However, the activity of IMP-6 was very low against penicillin G and piperacillin. These results suggest that IMP-6 acquired high activity against carbapenems, especially meropenem, via the point mutation but in the process lost activity against penicillins. Although IMP-6 has reduced activity against penicillins due to this point mutation, pKU501 confers resistance to a variety of antimicrobial agents because it also produces TEM-1-type enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302793      PMCID: PMC90471          DOI: 10.1128/AAC.45.5.1343-1348.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.

Authors:  M Inoue; R Okamoto; T Okubo; K Inoue; S Mitsuhashi
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

2.  A simple and efficient method for direct cloning of PCR products using ddT-tailed vectors.

Authors:  T A Holton; M W Graham
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

3.  High-copy-number and low-copy-number plasmid vectors for lacZ alpha-complementation and chloramphenicol- or kanamycin-resistance selection.

Authors:  S Takeshita; M Sato; M Toba; W Masahashi; T Hashimoto-Gotoh
Journal:  Gene       Date:  1987       Impact factor: 3.688

4.  Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.

Authors:  M D Kitzis; J F Acar; L Gutmann
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

5.  Transferable imipenem resistance in Pseudomonas aeruginosa.

Authors:  M Watanabe; S Iyobe; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

6.  Cloning and expression in Enterobacteriaceae of the extended-spectrum beta-lactamase gene from a Pseudomonas aeruginosa plasmid.

Authors:  S Iyobe; M Tsunoda; S Mitsuhashi
Journal:  FEMS Microbiol Lett       Date:  1994-08-15       Impact factor: 2.742

7.  Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae.

Authors:  G Cornaglia; K Russell; G Satta; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance.

Authors:  E Osano; Y Arakawa; R Wacharotayankun; M Ohta; T Horii; H Ito; F Yoshimura; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

9.  Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens.

Authors:  H Ito; Y Arakawa; S Ohsuka; R Wacharotayankun; N Kato; M Ohta
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

10.  Purification and characterization of metallo-beta-lactamase from Serratia marcescens.

Authors:  K Marumo; A Takeda; Y Nakamura; K Nakaya
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

View more
  48 in total

1.  First isolation of a carbapenem-hydrolyzing beta-lactamase in Pseudomonas aeruginosa in Spain.

Authors:  Guillem Prats; Elisenda Miro; Beatriz Mirelis; Laurent Poirel; Samuel Bellais; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

2.  Detection of a variant metallo-beta-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an alcaligenes xylosoxidans strain.

Authors:  Shizuko Iyobe; Haruko Kusadokoro; Ayako Takahashi; Sachie Yomoda; Toyoji Okubo; Akio Nakamura; Koji O'Hara
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa.

Authors:  Samuel Bellais; Olivier Mimoz; Sophie Léotard; Anne Jacolot; Olivier Petitjean; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis.

Authors:  Isabel C Materon; Anne Marie Queenan; Theresa M Koehler; Karen Bush; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

5.  In vitro evolution predicts that the IMP-1 metallo-beta-lactamase does not have the potential to evolve increased activity against imipenem.

Authors:  Barry G Hall
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

6.  IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa.

Authors:  Katy Jeannot; Laurent Poirel; Marjorie Robert-Nicoud; Pascal Cholley; Patrice Nordmann; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

7.  High frequency of IMP-6 among clinical isolates of metallo-β-lactamase-producing Escherichia coli in Japan.

Authors:  Hisakazu Yano; Miho Ogawa; Shiro Endo; Risako Kakuta; Hajime Kanamori; Shinya Inomata; Noriomi Ishibashi; Tetsuji Aoyagi; Masumitsu Hatta; Yoshiaki Gu; Mitsuhiro Yamada; Koichi Tokuda; Hiroyuki Kunishima; Miho Kitagawa; Yoichi Hirakata; Mitsuo Kaku
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

8.  Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate.

Authors:  Francisco José Pérez-Llarena; Ana Fernández; Laura Zamorano; Frédéric Kerff; Alejandro Beceiro; Belén Aracil; Emilia Cercenado; Elisenda Miro; Antonio Oliver; Jesús Oteo; Ferran Navarro; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2012-06-05       Impact factor: 5.191

9.  Carbapenem-resistant Pseudomonas aeruginosa in malaysia producing IMP-7 beta-lactamase.

Authors:  Siaw Eng Ho; Geetha Subramaniam; Selvi Palasubramaniam; Parasakthi Navaratnam
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  Meropenem and chromacef intermediates observed in IMP-25 metallo-β-lactamase-catalyzed hydrolysis.

Authors:  Peter Oelschlaeger; Mahesh Aitha; Hao Yang; Joon S Kang; Antonia L Zhang; Eleanor M Liu; John D Buynak; Michael W Crowder
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.